Viewing StudyNCT04270760



Ignite Creation Date: 2024-05-06 @ 2:18 PM
Last Modification Date: 2024-10-26 @ 1:28 PM
Study NCT ID: NCT04270760
Status: COMPLETED
Last Update Posted: 2023-09-07
First Post: 2020-02-13

Brief Title: Olpasiran Trials of Cardiovascular Events And LipoproteiNa Reduction - DOSE Finding Study
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Cardiovascular Disease
Keywords:
Name View
Dyslipidemia View
Olpasiran View
AMG 890 View
siRNA View
lipoprotein a Lpa View
Cardiovascular View
Cardiovascular disease View
Atherosclerotic cardiovascular disease View
Cholesterol View
Apolipoprotein B View
Hyperlipidemia View